212 related articles for article (PubMed ID: 34644148)
1. Ubiquitination and degradation of SUMO1 by small-molecule degraders extends survival of mice with patient-derived tumors.
Bellail AC; Jin HR; Lo HY; Jung SH; Hamdouchi C; Kim D; Higgins RK; Blanck M; le Sage C; Cross BCS; Li J; Mosley AL; Wijeratne AB; Jiang W; Ghosh M; Zhao YQ; Hauck PM; Shekhar A; Hao C
Sci Transl Med; 2021 Oct; 13(615):eabh1486. PubMed ID: 34644148
[TBL] [Abstract][Full Text] [Related]
2. SUMO1 degrader induces ER stress and ROS accumulation through deSUMOylation of TCF4 and inhibition of its transcription of StarD7 in colon cancer.
Zhao YQ; Jin HR; Kim D; Jung SH; Liu S; Wan J; Lo HY; Fu XQ; Wang Q; Hao C; Bellail AC
Mol Carcinog; 2023 Sep; 62(9):1249-1262. PubMed ID: 37191369
[TBL] [Abstract][Full Text] [Related]
3. Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2.
Gareau JR; Reverter D; Lima CD
J Biol Chem; 2012 Feb; 287(7):4740-51. PubMed ID: 22194619
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of ubiquitination and sumoylation of acrosin inhibitor during in vitro capacitation of porcine sperm.
Chen X; Liang W; Wang S; Lv Y; Han Y; Xu D; Jin Y
Anim Biotechnol; 2021 Oct; 32(5):646-655. PubMed ID: 34554078
[TBL] [Abstract][Full Text] [Related]
5. SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression.
Bellail AC; Olson JJ; Hao C
Nat Commun; 2014 Jun; 5():4234. PubMed ID: 24953629
[TBL] [Abstract][Full Text] [Related]
6. Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.
Ward CC; Kleinman JI; Brittain SM; Lee PS; Chung CYS; Kim K; Petri Y; Thomas JR; Tallarico JA; McKenna JM; Schirle M; Nomura DK
ACS Chem Biol; 2019 Nov; 14(11):2430-2440. PubMed ID: 31059647
[TBL] [Abstract][Full Text] [Related]
7. PIASxα ligase enhances SUMO1 modification of PTEN protein as a SUMO E3 ligase.
Wang W; Chen Y; Wang S; Hu N; Cao Z; Wang W; Tong T; Zhang X
J Biol Chem; 2014 Feb; 289(6):3217-30. PubMed ID: 24344134
[TBL] [Abstract][Full Text] [Related]
8. Arkadia/RNF111 is a SUMO-targeted ubiquitin ligase with preference for substrates marked with SUMO1-capped SUMO2/3 chain.
Sriramachandran AM; Meyer-Teschendorf K; Pabst S; Ulrich HD; Gehring NH; Hofmann K; Praefcke GJK; Dohmen RJ
Nat Commun; 2019 Aug; 10(1):3678. PubMed ID: 31417085
[TBL] [Abstract][Full Text] [Related]
9. A role for paralog-specific sumoylation in histone deacetylase 1 stability.
Citro S; Jaffray E; Hay RT; Seiser C; Chiocca S
J Mol Cell Biol; 2013 Dec; 5(6):416-27. PubMed ID: 24068740
[TBL] [Abstract][Full Text] [Related]
10. Interaction between
Yi J; Wang Y; Li Q; Zhang H; Shao Z; Deng X; He J; Xiao C; Wang Z; Wang Y; Chen C
J Vet Sci; 2019 Sep; 20(5):e54. PubMed ID: 31565897
[No Abstract] [Full Text] [Related]
11. Targeted protein degradation and the enzymology of degraders.
Fisher SL; Phillips AJ
Curr Opin Chem Biol; 2018 Jun; 44():47-55. PubMed ID: 29885948
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-mediated fluorescence complementation reveals that Jun ubiquitinated by Itch/AIP4 is localized to lysosomes.
Fang D; Kerppola TK
Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14782-7. PubMed ID: 15469925
[TBL] [Abstract][Full Text] [Related]
13. miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy.
Oh JG; Watanabe S; Lee A; Gorski PA; Lee P; Jeong D; Liang L; Liang Y; Baccarini A; Sahoo S; Brown BD; Hajjar RJ; Kho C
Circ Res; 2018 Aug; 123(6):673-685. PubMed ID: 30355233
[TBL] [Abstract][Full Text] [Related]
14. In vivo characterization of the properties of SUMO1-specific monobodies.
Berndt A; Wilkinson KA; Heimann MJ; Bishop P; Henley JM
Biochem J; 2013 Dec; 456(3):385-95. PubMed ID: 24040933
[TBL] [Abstract][Full Text] [Related]
15. SUMO paralogue-specific functions revealed through systematic analysis of human knockout cell lines and gene expression data.
Bouchard D; Wang W; Yang WC; He S; Garcia A; Matunis MJ
Mol Biol Cell; 2021 Sep; 32(19):1849-1866. PubMed ID: 34232706
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone receptor isoform-specific modification by small ubiquitin-like modifier (SUMO) modulates thyroid hormone-dependent gene regulation.
Liu YY; Kogai T; Schultz JJ; Mody K; Brent GA
J Biol Chem; 2012 Oct; 287(43):36499-508. PubMed ID: 22930759
[TBL] [Abstract][Full Text] [Related]
17. A stable chemical SUMO1-Ubc9 conjugate specifically binds as a thioester mimic to the RanBP2-E3 ligase complex.
Sommer S; Ritterhoff T; Melchior F; Mootz HD
Chembiochem; 2015 May; 16(8):1183-9. PubMed ID: 25917782
[TBL] [Abstract][Full Text] [Related]
18. Ang II Promotes SUMO2/3 Modification of RhoGDI1 Through Aos1 and Uba2 Subunits, and then Regulates RhoGDI1 Stability and Cell Proliferation.
Qi Y; Guan H; Liang X; Sun J; Yao W
Cardiovasc Drugs Ther; 2021 Aug; 35(4):769-773. PubMed ID: 33891248
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
[TBL] [Abstract][Full Text] [Related]
20. Methods to analyze STUbL activity.
Branigan E; Plechanovová A; Hay RT
Methods Enzymol; 2019; 618():257-280. PubMed ID: 30850055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
